Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Supranuclear Palsy, Progressive 1Spinal Cord Injuries 1Parkinson Disease 1Myasthenia Gravis 1Multiple System Atrophy 1Lewy Body Disease 1Essential Tremor 1Alzheimer Disease 1

Interventions

ravulizumab 3Tacrolimus 3Pyridostigmine Bromide 3Prednisone 3Mycophenolic Acid 3Data Collection 3Azathioprine 3efgartigimod alfa 2Steroids 2Diagnostic Self Evaluation 2Blood Specimen Collection 2rozanolixizumab 1Thymectomy 1Therapeutics 1Telemedicine 1Neurofeedback 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Genotype 1Cyclosporine 1Cyclophosphamide 1Biomarkers 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myasthenia Gravis × Neurofeedback × Clear all
NCT02761707 2019-07-18

Biomarkers in Neural Disorders

University of Pennsylvania

Completed
54 enrolled

Alzheimer Disease, Myasthenia Gravis, Parkinson Disease, Spinal Cord Injuries, Supranuclear Palsy, Progressive, Multiple System Atrophy, Essential Tremor, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡